BeStock  
Stocks › Biotechnology › PRME

Prime Medicine PRME

US equityMarket cap rank #3316Biotechnology
$3.55 −$0.29 (-7.55%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $3.56 +0.28%
Open$3.70
Prev close$3.84
Day range$3.49 – $3.94
Volume6.13M
Market cap$791.62M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$8.20+131.0% vs. price
  • Buy 100%
Low $6.00Now $3.55Avg $8.20High $11.00

Recent rating changes

The last 20 actions on file set price targets from $5.00 to $11.00, averaging $7.53.

DateFirmRatingTarget
13 Nov 2026 BMO Capital BUY $9.00
13 Nov 2026 Oppenheimer BUY $11.00
5 Oct 2026 LifeSci Capital BUY $6.00
1 Oct 2026 H.C. Wainwright BUY $8.00
25 Sep 2026 Oppenheimer BUY $11.00
24 Sep 2026 TD Cowen BUY –
24 Sep 2026 Chardan Capital BUY $7.00
24 Sep 2026 LifeSci Capital BUY $6.00
24 Sep 2026 BMO Capital BUY $9.00
25 Aug 2026 Chardan Capital BUY $7.00
19 Aug 2026 BMO Capital BUY $9.00
17 Aug 2026 LifeSci Capital BUY $6.00
10 Aug 2026 Morgan Stanley HOLD –
10 Aug 2026 H.C. Wainwright BUY $8.00
6 Aug 2026 LifeSci Capital BUY $6.00
6 Aug 2026 JonesTrading BUY $5.00
24 Jul 2026 LifeSci Capital BUY $6.00
11 Jul 2026 LifeSci Capital BUY $6.00
9 Jul 2026 H.C. Wainwright BUY $8.00
8 Jul 2026 Morgan Stanley HOLD –

Discussion

No comments yet — be the first to weigh in on PRME.

Sign in to join the discussion.

Scroll to Top